Advanced search
Publication Cover
Acta Cardiologica Volume 78, 2023 - Issue 8
Submit an article Journal homepage
142
Views
2
CrossRef citations to date
0
Altmetric
Original Scientific Papers

Prediction of the development of contrast‑induced nephropathy following percutaneous coronary artery intervention by machine learning

Xiao Maa Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China;b Guangxi Key Laboratory Base of Precision Medicine in Cardiocerebrovascular Diseases Control and Prevention, Nanning, P. R. China;c Guangxi Clinical Research Center for Cardiocerebrovascular Diseases, Nanning, P. R. ChinaView further author information
,
Changhua Moa Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China;b Guangxi Key Laboratory Base of Precision Medicine in Cardiocerebrovascular Diseases Control and Prevention, Nanning, P. R. China;c Guangxi Clinical Research Center for Cardiocerebrovascular Diseases, Nanning, P. R. ChinaView further author information
,
Yujuan Lia Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China;b Guangxi Key Laboratory Base of Precision Medicine in Cardiocerebrovascular Diseases Control and Prevention, Nanning, P. R. China;c Guangxi Clinical Research Center for Cardiocerebrovascular Diseases, Nanning, P. R. ChinaView further author information
,
Xinyuan Chena Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. ChinaView further author information
&
Chun Guia Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, P. R. China;b Guangxi Key Laboratory Base of Precision Medicine in Cardiocerebrovascular Diseases Control and Prevention, Nanning, P. R. China;c Guangxi Clinical Research Center for Cardiocerebrovascular Diseases, Nanning, P. R. ChinaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4484-3339View further author information
ORCID Icon
Pages 912-921 | Received 03 Aug 2022, Accepted 30 Mar 2023, Published online: 13 Apr 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Committed to improving the lives of patients with Type 2 Diabetes, Heart Failure and Chronic Kidney Disease.
Bristol Myers Squibb – symposium on hypertrophic cardiomyopathy.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.